Tern’s Wyld Networks receives SEK 12.6 million purchase order for its satellite IoT Wyld Connect module

Tern - Wyld Networks

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things technology businesses, has noted that Wyld Networks AB has today announced that it has received an approximately SEK 12.6 million (approximately £1 million) purchase order for its satellite IoT Wyld Connect module. 

Extracted from the Wyld Announcement

“Virtual satellite network operator Wyld Networks has been contracted to deliver its Wyld Connect satellite IoT module to a company based in the Middle East for deployment into the agricultural sector. Wyld Networks has received a purchase order with a total value of approximately SEK 12.6 million for delivery of Wyld Connect modules over a four-year period, starting in April 2023.

The Wyld Connect solution will allow for the customer to deploy IoT sensors in the agricultural sector to collect data directly from satellites.

‘We are pleased to announce the receipt of this purchase order. Since launching the network in December 2022, Wyld is actively engaged in commercial discussions to solicit purchase orders with multiple customers for the Wyld Connect IoT module and data service’, said Alastair Williamson, CEO of Wyld Networks.

Wyld’s sensor-to-satellite module allows IoT sensors to communicate directly from sensor to Low Earth Orbit satellites. Wyld’s portfolio of modems, devices, and embedded technologies enable communication with the cloud, no matter the location, providing 100% global IoT coverage.

The UN’s Food and Agriculture Organization has predicted that global food production in 2050 will need to be 70% higher than in 2009, as the world population grows by nearly a third. To meet this increase in food demand, agriculture is rapidly adopting the IoT to collect data from the field and allow informed decisions that increase the yield of crops, reduce the waste of water and improve sustainability.”

Tern holds 41.2% of Wyld Networks’ equity.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Evidence-based care pathways create clearer routes to adoption

Evidence-based care pathways can reduce delays, improve treatment consistency and support the adoption of new therapies.

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

Tern plc raises £450,000 in share placing ahead of AIM admission

Tern plc has raised £450,000 through a placing and outlined expected admission timing and updated voting rights.

AI search makes message measurement a healthcare priority

As AI changes search, healthcare companies need to know whether their messages are being seen, understood and represented correctly.

Search